KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Gains from Investment Securities (2017 - 2025)

Petmed Express' Gains from Investment Securities history spans 16 years, with the latest figure at -$164000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 2150.0% year-over-year to -$164000.0; the TTM value through Dec 2025 reached $125000.0, down 77.72%, while the annual FY2025 figure was $525000.0, 303.85% up from the prior year.
  • Gains from Investment Securities reached -$164000.0 in Q4 2025 per PETS's latest filing, down from $242000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.3 million in Q4 2022 to a low of -$164000.0 in Q4 2025.
  • Average Gains from Investment Securities over 5 years is $208428.4, with a median of $47000.0 recorded in 2023.
  • Peak YoY movement for Gains from Investment Securities: skyrocketed 8633.33% in 2022, then tumbled 2150.0% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $15000.0 in 2021, then surged by 8633.33% to $1.3 million in 2022, then tumbled by 96.72% to $43000.0 in 2023, then crashed by 81.4% to $8000.0 in 2024, then crashed by 2150.0% to -$164000.0 in 2025.
  • Per Business Quant, the three most recent readings for PETS's Gains from Investment Securities are -$164000.0 (Q4 2025), $242000.0 (Q3 2025), and -$4000.0 (Q2 2025).